Phase I study of ipilimumab in phased combination with paclitaxel and carboplatin in Japanese patients with non-small-cell lung cancer

類似資料

• A phase 1 study evaluating the pharmacokinetics and preliminary efficacy of veliparib (ABT-888) in combination with carboplatin/paclitaxel in Japanese subjects with non-small cell lung cancer (NSCLC)
  著者:: Mizugaki, Hidenori, 等
  出版事項: (2015)
• Randomized phase II study of sequential carboplatin plus paclitaxel and gefitinib in chemotherapy-naïve patients with advanced or metastatic non-small-cell lung cancer: Long-term follow-up results
  著者:: Kubo, Emi, 等
  出版事項: (2017)
• Five‐year safety and efficacy data from a phase Ib study of nivolumab and chemotherapy in advanced non‐small‐cell lung cancer
  著者:: Kanda, Shintaro, 等
  出版事項: (2020)
• Brain metastases after definitive concurrent chemoradiotherapy in patients with stage III lung adenocarcinoma: Carcinoembryonic antigen as a potential predictive factor
  著者:: Horinouchi, Hidehito, 等
  出版事項: (2012)
• Impact of KRAS mutation on response and outcome of patients with stage III non-squamous non-small cell lung cancer
  著者:: Yagishita, Shigehiro, 等
  出版事項: (2015)